Jext ® is expected to be the first AAI to market in China. Prior to registration in mainland China, Grandpharma plans to start selling Jext ® in southern China under a special licence linked to the ...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) to launch its adrenaline autoinjector (AAI), Jext®, in China via a partnership with leading supplier of adrenaline, Grandpharma. Jext® is expected to be the ...

ALK, a global specialty pharmaceutical company, and China Grand Pharmaceutical and Healthcare Holdings Limited (Grandpharma), an international pharmaceutical company, announced an exclusive licensing ...